Are There Sex Differences in sociodemographic background and cognitive Functions Among Patients With dementia,a comparative study among an Egyptian sample.

Slides:



Advertisements
Similar presentations
 Most common and important degenerative disease of the brain  Shrinkage in size and weight of the brain  Severe degree of diffuse cerebral atrophy.
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
DRAFT Promotional Copy for NNSDO 1 Cognitive / Mental Status Assessment of Older Adults.
Frontotemporal Dementia
Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.
Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.
Alzheimer’s Disease By Juan Escobar Per: 4. Alzheimer’s Disease  A common form of dementia of unknown cause, usually beginning in late middle age, characterized.
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
Rivermead Behavioural Memory Test performance in schizophrenic patients Ruiz, J.C. (1), Fuentes, I. (1), Tomás, P. (2), Soler, M.J. (1) and García Merita,
The Effects of Increased Cognitive Demands on the Written Discourse Ability of Young Adolescents Ashleigh Elaine Zumwalt Eastern Illinois University.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Dementia with Lewy Bodies
Mild Cognitive Impairment
MILD COGNITIVE IMPAIRMENT IN PATIENTS WITH CAROTID DISEASE Irena Martinic Popovic 1, M.D, Arijana Lovrencic-Huzjan 1, M.D, Ph. D, Ana-Maria Simundic 2,
ACT on Alzheimer’s Disease Curriculum Module VII: Disease Diagnosis.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Middle and Old Age. Maximum Recorded Life Spans Human Indian Elephant Gorilla Common Toad Domestic Cat Domestic Dog Vampire Bat House Mouse
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Multiple Choice Questions for discussion
EPIB-591 Screening Jean-François Boivin 29 September
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Cognitive Impairment Disorders. Assessing Brain Damage  Mental status examination  Information about current behavior and thought including orientation.
Introduction Neuropsychological Symptoms Scale The Neuropsychological Symptoms Scale (NSS; Dean, 2010) was designed for use in the clinical interview to.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
Interferences between depression and life quality on patients suffering of type 2 diabetes First Author : Madalina Crisan Coauthors: Madalina Salagean.
Laurence Lacoste Ph. D, Paris, France 1*. Introduction : Why ?  Population’s Ageing is a Public Health issue and dementia for the Elderly a reality 
Author : Gyero Reka Coordinator : Prof. Dr. Gabos Grecu Iosif
Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Alzheimer’s Disease By: Nora Teen Health 8 Period 1.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Epidemiology of Alzheimer’s Disease
DEMENTIA ABDULMAJEED ALOLAYAH What is DEMENTIA ? It is a chronic global impairment of cognitive functions without disturbed consciousness.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
The Alzheimer’s Disease Challenge: Take Your Knowledge Further ALZHEIMER’S DISEASE AND ITS MANAGEMENT: AN OVERVIEW.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Alzheimer’s disease.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Alzheimer’s Disease Stephanie Aparicio May 4, 2011 Period 5.
BY: GRACE STOUT. What is Alzheimer’s and what does it do to the human body?  Alzheimer’s Disease is a progressive, neurodegenerative disorder that is.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
Comparison of Risk Factors for Early-Onset versus Late-Onset Alzheimer Disease OBJECTIVE To compare early-onset (before 65) Alzheimer disease (AD) patients.
Biomedical Research Centre for Mental Health and Dementia Unit at South London and Maudsley NHS Foundation Trust the Institute of Psychiatry, King’s College.
The status of understanding Dementia and Living Environment of Korean elderly population Eun-Ah Lee, MD., Eun Hyang Song, MD., Joon Young Lee *, MD Department.
DIABETES AS A RISK FACTOR FOR COGNITIVE DECLINE IN OLDER PATIENTS F. Limongi, A. Marseglia, S. Maggi, M. Noale, G. Romanato, P. Siviero, G. Crepaldi CNR,
Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Dementia Jaqueline Raetz, M.D..
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Dementia Jaqueline Raetz, M.D..
CAREGIVER BURDEN AMONG CAREGIVERS OF PERSONS WITH DEMENTIA AND LATE ONSET DEPRESSIVE DISORDER AND ITS ASSOCIATION WITH PERCEIVED ELDER ABUSE Presenter:
Rhematoid Rthritis Respiratory disorders
Chapter 30 Delirium and Dementia
The Memory Assessment and Treatment Service (MATS)
Chapter 25 The Elderly.
Presentation transcript:

Are There Sex Differences in sociodemographic background and cognitive Functions Among Patients With dementia,a comparative study among an Egyptian sample. Ashour A. MD, Abd-Elrazek Gh. MD, Mahmoud A. MD, Hewedi D. MD.

Introduction

Sex difference in the degenerative dementias not well established until now and the prevalence of dementia still is the same in males and females except for dementia of Alzheimer ’ s type, which is reported to be higher in females.

But, several studies based on prevalent cases of dementia report a higher frequency of dementia in women compared with men. However, these finding may reflect differences between men and women in survival after dementia is detected.

Material and method

p. 22 males and 26 females patient selected from memory clinic which is a special outpatient psychogeriatric clinic diagnosed to have dementia with its different subtypes according to ICD10 symptoms check list, the total sample was screened with brief cognitive tests, and screen positives were investigated in a follow-up diagnostic assessment for assessment of different cognitive function, laboratory and radiological investigation were done if indicated.

Subjects

Subjects include those attending the memory clinic at the Ain Shams institute of psychiatry complaining of cognitive impairment, from march 2003 to march 2005, with the following Inclusion criteria : Age : above the age of 50 years. Nationality : of Egyption nationality. The individuals must be coming mainly with memory impairment as their primary presenting symptom.

Exclusion criteria: Difficult uncooperative patient due to –Late stage of dementia –Patient with aphasia. –Other causes.

Procedures

Study proper An information consent had obtained from each individual or their care givers. Full psychiatric assessment using symptoms chick list of ICD10 in order to obtain diagnosis according to ICD10 criteria for research. Full Neurological examination had done according to Ain-Shams university hospital neurological sheet. Full medical examination.

Mini-Mental State Examination was administered ( the Arabic version ) (MMSE): The MMSE is found to be valid and reliable in assessing a limited range of cognitive functions in a global way. This was followed by assessment of cognitive function using CAMCOG scale (Arabic version of cognitive section of CAMDEX scale).

which measures the following cognitive functions: Memory (learning, recent & remote memory ). Language (expression & comprehension Attension.Praxis.Calculation. Abstraction ( perception & thinking). Orientation. Neuropsychological assessment using Wchseler memory scale revised battery (WMS- R) which comprises eleven subtests measuring the following cognitive function: Attention & concentration. Verbal memory. Visual memory (performance ). General or total memory. Recall. Neuroimaging if indicated (CT brain, MRI ….ect). Laboratory investigation if indicated.

Statistical analysis

Statistical analysis was carried out by using means and SDs, analysis of variance by one way (ANOVA) test with repeated measures. Frequency distributions were calculated with chi- square tests `

Results

Table ( 1 ):shows the number & percent of patient diagnosed as dementia with its subtype attending the memory clinic through the period of research %NoDiagnoses Dementia of alz type 23.6%*13* Dementia of alz type with early onset 40%**22** Dementia of alz type with late onset 16.4%9 Multi-infarcts dementia 12.7%7 Pick ’ s disease 3.6%2 Lewy bodies dementia 3.6%2 Subcortical dementia

Table ( 1 ) : shows that Dementia of alz type with late onset was the commonest cognitive disorder presented to our clinic during this peroid

Table ( 2 ) : shows the distribution of dementia subtypes through defferent age groups Total % 80 < % 70 – 79 % 60 – 69 % 50 – 59 % 40 – 49 % 13 (23.6%) -5 (9.1%) -6 (10.9%)** 2 (3.6%) Dementia of alz type with early onset 22 (40%) 10 (18.2%)11 (20%)**-- Dementia of alz type with late onset 9 (16.4%) -6 (10.9%)** 2 (3.6%) - Multi- infarcts dementia 7 (12.7%) -1 (1.8%)6 (10.9%)**- Pick’s disease 2 (3.6%) ---2 (3.6%) - Lewy bodies dementia 2 (3.6%) ---1 (1.8%) 1 (1.8%) Subcortica l dementia.

Table ( 2 ) shows that: Dementia of alz type with early onset more common at the age from 50 – 59. Dementia of alz type with late onset was more common at the age from 70 – 79 Multi-infarcts dementia was more common at the age from 70 – 79

Figure (1): Gender percentage distribution of the studied group.

Figure (2): education percentage distribution of the female studied group

Figure (3): education percentage distribution of the male studied group

Table ( 3 ): the relation between dementia subtypes and gender. FemaleMale Diagnosis 5 (9.1%)8 (14.5%*) Dementia of alz type with early onset 15 (27.3%)*7 (12.7%) Dementia of alz type with late onset 3 (5.5%)6 (10.9%*) Multi-infarcts dementia 2 (3.6%)5 (9.1%) Pick’s disease 2 (3.6%)- Lewy bodies dementia. -2 (3.6%) Subcortical dementia.

This table shows the number of each gender group in each dementia subtype: The number of female patient diagnosed as Dementia of alz type with late onset were more than males while it was less than males in Dementia of alz type with early onset & Multi-infarcts dementia.

The data obtained from cognitive assessment and follow up clinically revealed that : Symptoms profiles and cognitive decline were to some extend similar in both males and females, but by follow up the course and rate of deterioration was slowly in women than in men and the response to medication, symptoms improvement, prognosis and mortality rate were better in females.

Discussion &Conclusion

We examined gender differences in a sample of demented patient attending the memory clinic through 2 years. Our analyses suggest that dementia of Alzheimer type with late onset appears to be more in females, this difference is due to a higher risk in women for AD. In addition to that by follow up of these patients we found that the course of progression, prognosis and outcome were better in females than in males. However the number of males attending memory clinic diagnosed as dementia with its different subtypes were more than females which may attributed to the following factors: The males considered as the caring of their families in Arab countries. So, the social & occupational deterioration rapidly noticed in males than females. Higher level of education in males than females in our countries increase the level of their awareness and early detection of their cognitive changes, however the low level of education is known to influence performance on cognitive screening tests resulting in higher proportion of screen positives among women. However, diagnosis was based on subsequent clinical examination, informant interviews, and more detailed neuropsychological testing these procedures would reduce the chance of diagnostic bias.

Many studies reported gender effects on cerebral glucose metabolic patterns, and that there was a strong correlation between brain adrenal axis activity and cognitive impairment in women but not in men. However, the more credited explanation for the gender difference relates to hormonal influences effects on cerebral glucose metabolic patterns.

Estrogen stimulates the action and viability of cholinergic neurons; it modulates axonal elongation and promotes the formation of dendritic spines and synapses, it promotes the breakdown of the amyloid precursor protein. In addition, estrogen has antioxidant properties and modifies some aspects of the inflammatory response mechanisms that have been implicated in the pathology of AD, Finally, estrogen increases cerebral glucose utilization and cerebral blood flow.

so from these studies we can revealed that before menopause, estrogen delay the incidence of AD, while after that the incidence is nearly the same.

In our finding we reported that multi- infarcts dementia is more common among male sex (66.7%) in our society this may be due to men are more liable to cerebrovascular insult due to the higher incidence of hypertension, diabetes, atheresclerosis, hypercholesterolemia that are considered as important risk factors for brain vascular insult on males more than females.